CollPlant Biotechnologies Ltd. said its ordinary shares will begin trading on Nasdaq as “OPHI” at the open on November 13, 2026, after closing under “CLGN” on November 12, 2026; no shareholder action is required.
OPHI · CollPlant Biotechnologies Ltd
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
The closing range uses available history since Nov 13, 2026; less than a full year is stored.
Up next
Latest documents
CollPlant Biotechnologies Ltd. subsidiary LightSolver will publicly demonstrate its all-optical Laser Processing Unit at SC26 in Chicago November 16-19, 2026, solving linear equations, differential equations and complex optimization problems, alongside Boeing corrosion-simulation benchmarks.
CollPlant Biotechnologies Ltd. said the Israel Innovation Authority approved an approximately $1.8 million grant for subsidiary LightSolver Ltd. to advance its Laser Processing Unit (LPU) development; receipt remains subject to the authority’s customary terms.
CollPlant Biotechnologies Ltd. proposed changing its name to OptiPhi Computing Ltd. and Nasdaq ticker from “CLGN” to “OPHI,” reflecting expansion into photonic computing after acquiring LightSolver Ltd. in September 2026; shareholder approval is required.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OPHI
this stock
CollPlant Biotechnologies Ltd
|
$11.23M | — | +360.4% | — | 0.0% |
|
VRTX
Vertex Pharmaceuticals Inc
|
$136.56B | +18.8% | +46.2% | 34.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$98.84B | +23.8% | +20.8% | 21.1 | 2.1% |
|
MRNA
Moderna, Inc.
|
$90.38B | +657.4% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$66.05B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 11.5%
- Reported
- 14 of 15
- Top holder
- BROWN ADVISORY INC
- Filed
- Nov 12, 2026
- This year
- 38
CollPlant Biotechnologies Ltd. said its ordinary shares will begin trading on Nasdaq as “OPHI” at the open on November 13, 2026, after closing under “CLGN” on November 12, 2026; no shareholder action is required.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OPHI | — | — | — | — | — |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | — | — | — | — | — |